TrialBMC medicine2025

Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled study.

Kaibo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.